Cargando…
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
BACKGROUND: Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates. It is approved for twice-daily dosing with no need f...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680490/ https://www.ncbi.nlm.nih.gov/pubmed/33063176 http://dx.doi.org/10.1007/s40121-020-00351-0 |